• NINTEDANIB CHEMBL502835 FDA ApprovedAntineoplastic

    Alternate Names:

    Nintedanib
    Ofev
    BIBF-1120
    178102559
    5936
    CHEBI:85164
    XIN
    METHYL (Z)-3-(((4-(N-METHYL-2-(4-METHYLPIPERAZIN-1-YL)ACETAMIDO)PHENYL)AMINO)(PHENYL)METHYLENE)-2-OXOINDOLINE-6-CARBOXYLATE
    METHYL (3Z)-3-[[4-[METHYL-[2-(4-METHYLPIPERAZIN-1-YL)ACETYL]AMINO]ANILINO]-PHENYL-METHYLENE]-2-OXO-INDOLINE-6-CARBOXYLATE
    METHYL (3Z)-3-[(4-{METHYL[(4-METHYLPIPERAZIN-1-YL)ACETYL]AMINO}ANILINO)(PHENYL)METHYLIDENE]-2-OXO-2,3-DIHYDRO-1H-INDOLE-6-CARBOXYLATE
    METHYL (3Z)-3-[({4-[N-METHYL-2-(4-METHYLPIPERAZIN-1-YL)ACETAMIDO]PHENYL}AMINO)(PHENYL)METHYLIDENE]-2-OXO-1H-INDOLE-6-CARBOXYLATE
    3-Z-[1-(4-(N-((4-METHYL-PIPERAZIN-1-YL)-METHYLCARBONYL)-N-METHYL-AMINO)-ANILINO)-1-PHENYL-METHYLENE]-6-METHOXYCARBONYL-2-INDOLINONE
    (Z)-METHYL 3-(((4-(N-METHYL-2-(4-METHYLPIPERAZIN-1-YL)ACETAMIDO)PHENYL)AMINO)(PHENYL)METHYLENE)-2-OXOINDOLINE-6-CARBOXYLATE
    BIBF1120, BIBF 1120, BIBF-1120 , VARGATEF, 928326-83-4
    BRD-K49075727-001-01-0
    D10481
    A10955
    Y0352
    X7367
    AB1006397
    AB0035905
    SMR004701273
    KB-75518
    HY-50904
    BC297819
    AK170374
    BIBF1120-SUPPLIED BY SELLECK CHEMICALS
    RL05845
    KS-1434
    CS-0104
    BCP9000405
    AN-5281
    ACN-030189
    ZINC100014909
    BIBF1120,BIBF-1120,VARGATEF/
    BIBF 1120|||INTEDANIB|||VARGATEF
    AKOS005145820
    RS0107
    BDBM50026612
    ABP000857
    XZXHXSATPCNXJR-ZIADKAODSA-N
    MOLPORT-009-679-380
    SYN1091
    AOB5742
    QCR-43
    GTPL5936
    G6HRD2P839
    SCHEMBL431007
    SCHEMBL431006
    MLS006010165
    NINTEDANIB (BIBF-1120)
    NINTEDANIB (BIBF 1120)
    CC-88
    VARGATEF, BIBF 1120
    NINTEDANIB [USAN:INN]
    NINTEDANIB (USAN/INN)
    BIBF1120 - VARGATEF
    TUBE722
    PUBCHEM20543
    BIBF1120,VARGATEF
    S1010_SELLECK
    METHYL (3Z)-3-[({4-[N-METHYL-2-(4-METHYLPIPERAZIN-1-YL)ACETAMIDO]PHENYL}AMINO)(PHENYL)METHYLIDENE]-2-OXO-2,3-DIHYDRO-1H-INDOLE-6-CARBOXYLATE
    METHYL (3Z)-3-(((4-(N-METHYL-2-(4-METHYLPIPERAZIN-1-YL)ACETAMIDO)PHENYL)AMINO)(PHENYL)METHYLIDENE)-2-OXO-2,3-DIHYDRO-1H-INDOLE-6-CARBOXYLATE
    OFEVREG
    VARGATEFREG
    METHYL (3Z)-3-{[(4-{METHYL[(4-METHYLPIPERAZIN-1-YL)ACETYL]AMINO}PHENYL)AMINO](PHENYL)METHYLIDENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE-6-CARBOXYLATE
    1160294-26-7
    C31H33N5O4
    VARGATEF, BIBF1120
    (Z)-METHYL 3-((4-(N-METHYL-2-(4-METHYLPIPERAZIN-1-YL)ACETAMIDO)PHENYLAMINO)(PHENYL)METHYLENE)-2-OXOINDOLINE-6-CARBOXYLATE
    UNII-G6HRD2P839
    656247-17-5
    INTEDANIB
    BIBF 1120
    928326-83-4
    BIBF1120
    VARGATEF
    9809715
    DB09079

    Drug Info:

    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications antineoplastic agent
    Drug Categories therapeutic uses
    Drug Categories protein kinase inhibitors
    Drug Categories pharmacologic actions
    Drug Categories p-glycoprotein/abcb1 substrates
    Drug Categories molecular mechanisms of pharmacological action
    Drug Categories heterocyclic compounds, 2-ring
    Drug Categories heterocyclic compounds
    Drug Categories enzyme inhibitors
    Drug Categories chemical actions and uses
    Drug Categories antineoplastic and immunomodulating agents
    Drug Categories antineoplastic agents
    Drug Groups approved
    Drug Type small molecule
    Drug Class Kinase Inhibitors
    (5 More Sources)